Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 31 Aug 2026
- Closes
- 2 Oct 2028, 23:59 UTC
- Reference
- PAR-27-068
- Location
- United States
- Sector
- Healthcare & Pharma
Details
This Notice of Funding Opportunity (NOFO) supports "mature" resources at synchrotron facilities that provide user access to X-ray beamlines for static and dynamic imaging of biological systems ranging from molecules to organs. "Mature" refers to the techniques made available at the resource beamlines, which must be well established and provide utility to the communities they serve without requiring significant novel technology development. Applications may only request support for existing synchrotron resources that are currently supported by NIGMS funding. The facility is expected to be maintained or upgraded to current best practices, make its capabilities and availability known to the biomedical research community through outreach activities, and provide user training and support.This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. Eligibility: Requirement for Current NIGMS Support: This NOFO is limited to applicants requesting support for existing synchrotron resources that are currently supported by NIGMS funding. Applications cannot support resources whose funding ended more than 36 months prior to the application due date.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
CFDA number(s): 93.859
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 411 notices from National Institutes of Health, going back to May 2023 — 383 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 380 open Healthcare & Pharma tenders in United States. This one closes in 736 days.
More from this buyer
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)· closes 5 Nov
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)· closes 25 May
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)· closes 16 Nov
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)· closes 10 Nov
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)· closes 9 Oct
Similar Healthcare & Pharma tenders
- Development of monoclonal antibodies to prevent and treat infections from Flaviviruses· closes 13 Apr
- Development of cell-free protein synthesis platforms for discovery and/or production of biologicals· closes 13 Apr
- Advancing bio-printing of living cells for regenerative medicine· closes 22 Sept
- Development of innovative antimicrobials against pathogens resistant to antimicrobials· closes 13 Apr
- Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential· closes 13 Apr
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Open House: Partners Jeugdhulp segment 2, 3 en 4 Noord-LimburgModulaire Gemeenschappelijke Regeling Sociaal Domein Limburg-Noord · Netherlands
- DAS ICT TabletsStichting Protestants Christelijk Primair Onderwijs Groene Hart · Netherlands
- DAS TabletsQuadraten · Netherlands
- Hoogspecialistische Jeugdhulp ('HSJ')Regionale Inkooporganisatie Groninger Gemeenten (RIGG) · Netherlands
- Apeldoorn Werkt MeeGemeente Apeldoorn, team Inkoop · Netherlands
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →